BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 17543230)

  • 1. Pesticides and metals induced Parkinson's disease: involvement of free radicals and oxidative stress.
    Singh C; Ahmad I; Kumar A
    Cell Mol Biol (Noisy-le-grand); 2007 May; 53(5):19-28. PubMed ID: 17543230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Free radicals in Parkinson's disease.
    Koutsilieri E; Scheller C; Grünblatt E; Nara K; Li J; Riederer P
    J Neurol; 2002 Sep; 249 Suppl 2():II1-5. PubMed ID: 12375056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental-induced oxidative stress in neurodegenerative disorders and aging.
    Migliore L; Coppedè F
    Mutat Res; 2009 Mar; 674(1-2):73-84. PubMed ID: 18952194
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Free radicals and ailing proteins--the culprits behind Parkinson disease?].
    Smith R; Lotharius J; Brundin P
    Lakartidningen; 2003 Apr; 100(15):1324-6, 1329-30. PubMed ID: 12739402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The current state of free radicals in Parkinson's disease. Nigral iron as a trigger of oxidative stress.
    Friedman A; Galazka-Friedman J
    Adv Neurol; 2001; 86():137-42. PubMed ID: 11553971
    [No Abstract]   [Full Text] [Related]  

  • 6. [Metals and oxidative stress in Parkinson's disease from industrial areas with exposition to environmental toxins or metal pollution].
    Squitti R; Gorgone G; Binetti G; Ghidoni R; Pasqualetti P; Draicchio F; Albini E; Benedetti L; Lucchini R; Rossini PM
    G Ital Med Lav Ergon; 2007; 29(3 Suppl):294-6. PubMed ID: 18409692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitrite and malondialdehyde content in cerebrospinal fluid of patients with Parkinson's disease.
    Shukla R; Rajani M; Srivastava N; Barthwal MK; Dikshit M
    Int J Neurosci; 2006 Dec; 116(12):1391-402. PubMed ID: 17145675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of pesticides on proteasome activity: implication in Parkinson's disease.
    Wang XF; Li S; Chou AP; Bronstein JM
    Neurobiol Dis; 2006 Jul; 23(1):198-205. PubMed ID: 16626962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of centrophenoxine against rotenone-induced oxidative stress in an animal model of Parkinson's disease.
    Verma R; Nehru B
    Neurochem Int; 2009 Nov; 55(6):369-75. PubMed ID: 19375462
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Environmental toxins and Parkinson's disease: putative roles of impaired electron transport chain and oxidative stress.
    Abdulwahid Arif I; Ahmad Khan H
    Toxicol Ind Health; 2010 Mar; 26(2):121-8. PubMed ID: 20207656
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biochemical and toxicological evidence of neurological effects of pesticides: the example of Parkinson's disease.
    Moretto A; Colosio C
    Neurotoxicology; 2011 Aug; 32(4):383-91. PubMed ID: 21402100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Etiology and pathogenesis of parkinson's disease].
    Mizuno Y; Ikebe S; Mochizuki H; Matumine H; Kondo T
    No To Shinkei; 1996 Jan; 48(1):5-17. PubMed ID: 8679319
    [No Abstract]   [Full Text] [Related]  

  • 13. Oxidative stress and neuroprotection in Parkinson's disease: implications from studies on dopamine-induced apoptosis.
    Offen D; Hochman A; Gorodin S; Ziv I; Shirvan A; Barzilai A; Melamed E
    Adv Neurol; 1999; 80():265-9. PubMed ID: 10410731
    [No Abstract]   [Full Text] [Related]  

  • 14. Pesticides and Parkinson's disease.
    Le Couteur DG; McLean AJ; Taylor MC; Woodham BL; Board PG
    Biomed Pharmacother; 1999 Apr; 53(3):122-30. PubMed ID: 10349500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic effects of dopamine metabolism in Parkinson's disease.
    Hattoria N; Wanga M; Taka H; Fujimura T; Yoritaka A; Kubo S; Mochizuki H
    Parkinsonism Relat Disord; 2009 Jan; 15 Suppl 1():S35-8. PubMed ID: 19131041
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polyhydroxylated fullerene derivative C(60)(OH)(24) prevents mitochondrial dysfunction and oxidative damage in an MPP(+) -induced cellular model of Parkinson's disease.
    Cai X; Jia H; Liu Z; Hou B; Luo C; Feng Z; Li W; Liu J
    J Neurosci Res; 2008 Dec; 86(16):3622-34. PubMed ID: 18709653
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of Parkinson's disease.
    Bonnet AM; Houeto JL
    Biomed Pharmacother; 1999 Apr; 53(3):117-21. PubMed ID: 10349507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autism and Parkinson's disease.
    Woodward G
    Med Hypotheses; 2001 Feb; 56(2):246-9. PubMed ID: 11425297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redox imbalance.
    Berg D; Youdim MB; Riederer P
    Cell Tissue Res; 2004 Oct; 318(1):201-13. PubMed ID: 15365815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controlling the mass action of alpha-synuclein in Parkinson's disease.
    Kim C; Lee SJ
    J Neurochem; 2008 Oct; 107(2):303-16. PubMed ID: 18691382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.